title: Is there any protective effect on organs upon higher uric acid level in tumor lysis syndrome?
authors.forename: Abdulkadir
authors.initials: A
authors.lastname: Basturk
authors.forename: Tuba
authors.initials: T
authors.lastname: Hacibekiroglu
authors.forename: Sema
authors.initials: S
authors.lastname: Akinci
authors.forename: Imdat
authors.initials: I
authors.lastname: Dilek
authors.forename: Haci Veli
authors.initials: HV
authors.lastname: Atalay
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects; D011743:Pyrimidines / Q000009:adverse effects; D015275:Tumor Lysis Syndrome / Q000209:etiology / Q000652:urine*; D014527:Uric Acid / Q000652:urine*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D014527:Uric Acid; D000068877:Imatinib Mesylate